Skip to main content

Dr. Mabel Yau

Pediatric Endocrinology (Pediatric Endocrinology Physician)

At a glance

Years since graduation
19
In the NPI registry since
2008

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2007Medical school: Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc)
  • 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pediatric Endocrinology Physician primary
    NY license 256039
  • Pediatrics Physician
    NY license 256039
  • Student in an Organized Health Care Education/Training Program

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pediatric Endocrinology per capita by county →

Where they work

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Payments from drug and device companies

In 2025, 4 companies reported 7 payments worth $3,976 in total to this clinician.

By company
Novo Nordisk Inc$2,790
Eton Pharmaceuticals, Inc.$1,075
BioMarin Pharmaceutical Inc.$71.47
AbbVie Inc.$39.49
By type
Consulting Fee$3,865
Food and Beverage$111

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Apr 17, 2025Novo Nordisk Inc
Apr 17, 2025
Consulting Fee
Sogroya · Growth Hormone
$1,860
Apr 21, 2025Eton Pharmaceuticals, Inc.
Apr 21, 2025
Consulting Fee
ALKINDI; KHINDIVI; INCRELEX · Endocrinology
$1,075
Apr 10, 2025Novo Nordisk Inc
Apr 10, 2025
Consulting Fee
Sogroya · Growth Hormone
$465
Apr 18, 2025Novo Nordisk Inc
Apr 18, 2025
Consulting Fee
Sogroya · Growth Hormone
$465

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,115 in research payments for these studies, mostly to the institutions running them.

  • Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
    Neurocrine Biosciences, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Pediatric Endocrinology clinicians in New York

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 10, 2013), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1710130893. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.